Search
for
Sort by
Research 301–330 of 1000+
- A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
- Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Effects of the chronic use of finasteride on testicular weight and spermatogenesis in Wistar rats
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy
- Combination therapy with finasteride and low-dose dutasteride in the treatment of androgenetic alopecia
- Discontinuation of Alpha-Blockade after Initial Treatment with Finasteride and Doxazosin for Bladder Outlet Obstruction
- Structural characterization of polymorphs and molecular complexes of finasteride
- Investigation of intermolecular interactions in finasteride drug crystals in view of X-ray and Hirshfeld surface analysis
- A Pharmacogenetic Survey of Androgen Receptor (CAG)N and (GGN)N Polymorphisms in Patients Experiencing Long Term Side Effects after Finasteride Discontinuation
- THERAPEUTIC HOTLINE: Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics
- Saturable Binding of Finasteride to Steroid 5α-reductase as Determinant of Nonlinear Pharmacokinetics
- Post-finasteride syndrome
- Protective effects of finasteride against testosterone-induced calcium oxalate crystallization and crystal-cell adhesion
- Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis
- Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease
- Finasteride is effective for the treatment of central serous chorioretinopathy
- Spectrofluorimetric study of finasteride and bovine serum albumin interaction and its application for quantitative determination of finasteride in tablet dosage form
- Iontophoretic Transdermal Delivery of Finasteride in Vesicular Invasomal Carriers
- Secondary infertility due to use of low-dose finasteride
- Finasteride, a 5α-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat
- A rapid, simple, specific liquid chromatographic–electrospray mass spectrometry method for the determination of finasteride in human plasma and its application to pharmacokinetic study
- Finasteride improves male pattern hair loss in a randomized study in identical twins.
- Effects of the anti-androgen finasteride on 5alpha-reductase activity in human gingival fibroblasts in response to minocycline
- Finasteride-Induced Gynecomastia in a 62-Year-Old Man
- Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men.